Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger
Recce Pharmaceuticals (ASX:RCE) has been on a tear this year. It's developing anti-infective, R327, with clinical results across Diabetic Foot Infection, Acute Bacterial Skin & Skin Structure Infection, and, Urosepsis/UTIs which point to a potential commercial value proposition. It also has a recent key relationship in Indonesia.
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Announcements
Filter Results
ECU | Appendix 3B - Options | 10/12/08 | ||
AGK +ECU | Galilee Energy Update | PRICE SENSITIVE | 05/12/08 | |
AGK +ECU | Glenaras Drilling Report | PRICE SENSITIVE | 03/12/08 | |
ECU | Presentation to Coal Seam Gas conference | 26/11/08 | ||
ECU | Results of Meeting | 25/11/08 | ||
ECU +RIO | QCPL withdraws from Broughton purchase | PRICE SENSITIVE | 20/11/08 | |
ECU | Galilee Rights Issue | PRICE SENSITIVE | 20/11/08 | |
ECUAppendix 3B - Options | |||
10/12/08 | 1.06MB | ||
AGK +ECUGalilee Energy Update | |||
05/12/08 | PRICE SENSITIVE | 2.28MB | |
AGK +ECUGlenaras Drilling Report | |||
03/12/08 | PRICE SENSITIVE | 57.18KB | |
ECUPresentation to Coal Seam Gas conference | |||
26/11/08 | 3MB | ||
ECUResults of Meeting | |||
25/11/08 | 780.28KB | ||
ECU +RIOQCPL withdraws from Broughton purchase | |||
20/11/08 | PRICE SENSITIVE | 34.65KB | |
ECUGalilee Rights Issue | |||
20/11/08 | PRICE SENSITIVE | 35.29KB | |